Dr. Shimabukuro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3288 Moanalua Rd
Honolulu, HI 96819Phone+1 808-432-0000Fax+1 808-432-7736
Education & Training
University of California (San Diego) Medical CenterFellowship, Hematology and Medical Oncology, 2007 - 2010- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2003 - 2006
Icahn School of Medicine at Mount SinaiClass of 2003
Certifications & Licensure
CA State Medical License 2005 - Present
HI State Medical License 2014 - 2026- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Lenalidomide in Treating Patients With AIDS-Associated Kaposi's Sarcoma Start of enrollment: 2010 Aug 27
Publications & Presentations
PubMed
- 7 citationsAMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma.Erin G Reid, Kelly Shimabukuro, Page Moore, Richard F Ambinder, Jack D Bui
Clinical Cancer Research. 2022-06-13 - 71 citationsOn the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 PatientsMaria Schwaederle, Gregory A. Daniels, David Piccioni, Paul T. Fanta, Richard Schwab
Molecular Cancer Therapeutics. 2015-06-01 - 37 citationsGenomics of gallbladder cancer: the case for biomarker-driven clinical trial designJason K. Sicklick, Paul T. Fanta, Kelly A. Shimabukuro, Razelle Kurzrock
Cancer Metastasis Reviews. 2016-02-09
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
